BrainsWay Ltd. announced on June 4, 2025, a strategic equity financing agreement with Stella MSO, LLC, a management services organization. Under the terms of the agreement, BrainsWay will invest $5 million in Stella Mental Health. This investment secures a minority position for BrainsWay in Stella, structured as a preferred, annually compounding security.
Stella Mental Health services over 20 mental health clinics across the U.S. and Israel, having treated more than 30,000 patients. This investment is the first in a series of planned minority-stake investments in high-performing providers. The initiative aims to accelerate access to and awareness of innovative mental health treatments like Deep TMS Therapy.
BrainsWay's CEO, Hadar Levy, stated that this strategy allows the company to maintain its core focus on scientific and clinical advancement of its technology. The investment provides growth capital to Stella, enabling it to scale its business and facilitate care to more patients. This move is part of BrainsWay's broader strategic initiative to expand its market presence.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.